I’m always interested in how Government ties in with the markets. It’s been a bit of a hobby of mine, along with WWII battles, over the past 2-3 years and there’s no bigger tie then Goldman and the Government then recently…and BOY is it bigger then we know! In my recent late night surfing I came across Greg Roy. Greg recently released a special report with the same title of this blog post, Goldman Sachs’ Next Slaughter of the Stock Market Lambs, and being the digger I am, I read the full report and cold called him. I asked if I could repost a part of the report for my Trader’s Blog members. After some convincing he said ok.

This guy knows what he is talking about… Here is an exclusive excerpt from his newly released report Goldman Sachs’ Next Slaughter of the Stock Market Lambs.

===================================================================

Goldman Sachs

...

Quick Analysis of Follow-On BiologicsOn June 10, 2009, the U.S. Federal Trade Commission (FTC) issued a 120-page report providing a competitive analysis of allowing generic biologics, or follow-on biologics (FOB).  The full report can be found on the FTC's website here.The Hatch-Waxman Act, which essentially created the generic pharmaceutical industry in 1984, does not apply to biologics. Hatch-Waxman paved the way for generic small molecules by allowing two pathways for approval. The first is an Abbreviated New Drug Application (ANDA), which allows for the filing for approval by a generic manufacturer using safety and efficacy data from the original developer, and the 505(b)(2) pathway, which allows for use of non-originated data to support changes in formulation of administration without having to conduct large-scale clinical programs.There is currently no path to approval for generic or alternative biologic molecules as exists for small ...

WASHINGTON -- May 15 2009 -- A group of representatives from major wind industry companies today released a letter to key members of Congress urging them to strengthen the renewable electricity standard (RES) contained in the draft bill unveiled this week by House Energy and Commerce Committee chairman Henry Waxman.

GWS Technologies, Inc. (OTCBB: GWSC), an alternative energy company developing renewable energy solutions, stands to benefit from a recent EPA ruling and proposed climate bill.

House Energy and Commerce Committee Chairman Henry Waxman has proposed a climate bill that would require businesses to reduce their greenhouse gas emissions by twenty percent by 2020. The bill will begin its opening round of debate in Congress this week. The hearings will follow the Environmental Protection Agency’s ruling last week that greenhouse gases pose a danger to the public, a finding that opens the way for new regulation of cars, power plants and factories.

Mr. Waxman also stated that he believes that most of the estimated $646 billion in revenue raised from carbon permits under the proposed cap-and-trade system should be spent on green technologies.

These developments make the recent announcement from GWSC that it has teamed with Sustainable Eco-Green Development Co. to develop

...

Obama's Healthcare Plan Is Big Bark, Small Bite by Jason Napodano, CFA

When President Obama's administration released the proposed budget for the upcoming fiscal year, drug stocks quickly dropped. Fears of socialized medicine, or "Hillary-Care 2.0" turned investors away from the sector.

Was the drop warranted?

There are 6 key components to healthcare reform that could have a meaningful impact on pharmaceutical and biotechnology companies in the near future.Four of these are potentially negative, whereas the other 2 are potentially positive.

First Potential Negative: Increasing Pricing Rebates

The new proposal calls for an increase in Medicaid rebates from the current level of 15% to 21%. This equates to a 6% decrease in pricing power by all the companies in our universe into the Medicaid market. If we delve deeper into the ramification of this

...

Highlighted companies include Genentech, inc. (DNA), Amgen, Inc. (AMGN) and Wyeth (WYE).Waxman's Bill Bad for Biotech Companies (and Doctors, Patients and America)California Representative Henry Waxman (D-CA), Chairman of the House Energy and Commerce Committee, has proposed legislation, along with his colleagues, that would give the U.S. Food and Drug Administration (FDA) the authority to approve generic (bioequivalent) versions of biotech drugs. As of now, there exists no path to approval for so called follow-on biologics as there is with small-molecule pharmaceutical products.According to the Wall Street Journal, the main contention on the bill remains how many years of market exclusivity a product would receive after approval. Mr. Waxman is calling for 5 years, whereas the biotech companies and trade organizations are asking for 14 years.This is a serious issue for investors in biotechnology stocks, in our view. Allowing ...

A significant piece of legislation that is part of President Obama’s stimulus package could open parts of the U.S. to new high-speed Internet services – giving local economies a boost. If so, we’ve identified one company that investors should consider buying in anticipation of a key piece of legislation that was passed last week.

High-speed Internet can exert a profound impact on how local businesses and consumers improve their own personal productivity and expand their entertainment venues. Our thinking here is very much along the lines of our “Cell Phone Indicator” that we use in emerging markets – improved communications boost the local economy.

The House Energy and Commerce Committee approved $6 billion in rules for billions in government funds to spur high-speed Internet networks in unserved and underserved areas.

The Internet funding portion of the stimulus bill — a potential huge boon to phone, cable, and wireless companies – helps fulfill President

...

President Barack Obama and Congressional leaders are having difficulty finding common ground on an economic recovery plan as Republican resistance to the stimulus package emerges in the House. The president and top Democrats and Republicans from the House and Senate planned to meet today to discuss the spending and tax cutting legislation that Obama has demanded to tackle the gloomy economy.

Yesterday, The House Ways and Means Committee approved $275 billion in tax cuts on a party-line vote of 24-13. The House Energy and Commerce Committee, also working on the bill, approved $2.8 billion to expand broadband service into underserved areas. And on Wednesday night, the House Appropriations Committee cleared a $358 billion spending measure on a 35-22 party-line vote.

Let us hear your thoughts below: